Paper

0

Document

Download

Flag content

0

Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial

Show More

Authors

Mansoor Mirza,Elisabeth Lundqvist

Michael Birrer,René Christensen,Gitte-Bettina Nyvang,Susanne Malander,Maarit Anttila,Theresa Werner,Bente Lund,Gabriel Lindahl,Sakari Hietanen,Ulla Peen,Maria Dimoula,Henrik Roed,Anja Knudsen,Synnöve Staff,Anders Vistisen,Line Bjørge

+16 authors

,Johanna Mäenpää

Journal

The Lancet Oncology

Published

Aug 29, 2019

DOI

10.1016/s1470-2045(19)30515-7

Show more

Save

Tip

Document

Download

Flag content

0

Tip

Save

Document

Download

Flag content